BridgeBio Pharma Inc (BBIO) — Defensive Interval Ratio
BridgeBio Pharma Inc (BBIO) has a Defensive Interval Ratio of 201 days as of September 2025. Defensive assets of $119.51 Million (cash $-, short-term investments $2.99 Million, receivables $116.52 Million) cover 201 days of daily cash needs of $593.42K/day. See how liquid is BridgeBio Pharma Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
BridgeBio Pharma Inc Defensive Interval Ratio (2019–2024)
This chart shows how BridgeBio Pharma Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 201 days, meaning defensive assets of $119.51 Million can fund 201 days of operations without new revenue. See BridgeBio Pharma Inc balance sheet independence to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for BridgeBio Pharma Inc (2019–2024)
The table below presents the year-by-year Defensive Interval Ratio for BridgeBio Pharma Inc from 2019 to 2024, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see BridgeBio Pharma Inc market cap and net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 11 days | $4.72 Million | $423.01K/day | $- | $0.00 | ▼ -143 days |
| 2023 | 154 days | $60.70 Million | $394.09K/day | $- | $58.95 Million | ▼ -184 days |
| 2022 | 338 days | $112.31 Million | $332.68K/day | $- | $95.23 Million | ▼ -913 days |
| 2021 | 1250 days | $462.64 Million | $370.05K/day | $- | $442.89 Million | ▲ +292 days |
| 2020 | 958 days | $251.01 Million | $262.05K/day | $- | $251.01 Million | ▼ -161 days |
| 2019 | 1119 days | $185.06 Million | $165.44K/day | $- | $182.22 Million | — |